Global Medical Foods Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431688
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Danone S.A
  • Entera Health,
  • Fresenius Kabi AG
  • Metagenics, Inc.
  • Nestle S.A.
  • MORE
Medical Foods Market - (Therapeutic Type - Pain Management, Sleep Management, Obesity and Hypertension, Cognitive Disorders, Viral Infections, Neuro-Degenerative Disorders, and Inborn Errors of Metabolism); (Application - Diabetic Neuropathy, ADHD, Depression, Alzheimer’s Disease, Nutrition Deficiency, and others): Market Growth, Future Prospects and Competitive Analysis, 2017-2025, the market was valued at US$ 9,857.2 Mn in 2016, and is expected to reach US$ 20,023.9 Mn by 2025, expanding at a CAGR of 8.1% from 2017 to 2025.

Market Insights

Medical foods are specialized formulations intended as dietary supplement for specific diseases with unique nutritional needs, which cannot be met with the usual dietary pattern. Medical foods are custom made and are administered enterally. These products are majorly used to treat patients with post-traumatic stress syndrome, osteoporosis, end stage renal disease, infants with NEC, cancer, Alzheimer’s disease and others. The overall strength of this market lies in the growth in patent awards and growth in recognition of medical foods. Market players are protecting their products with patenting on ingredients or formulation methods. Significant patent activity is being observed in the U.S. market. Nestec, incorporating the R&D of Nestle has filed almost twice as many patents in this field. Other companies such as Abbott Nutrition and Nutricia also significantly feature in this area. Strong market drivers such as growing prevalence of chronic diseases, increasing geriatric population and demand for enteral nutrition and personalized medicine further strengthens the market position of medical foods.

In terms of therapeutic area, inborn errors of metabolism segment was observed as the largest market because medical food is the only recognized therapy for many inborn errors of metabolism identified on newborn screening. It is observed that more than 3000 children born per year require the use of medical foods in the U.S. It is estimated that, due to the rising number of target population and increasing demand for alternate therapies medical foods for neurodegenerative disorders will show fastest market growth during forecast period. Application segment was dominated by diabetic neuropathy due to rampant increase in the prevalence of diabetes worldwide. It is predicted that the number of people with diabetes worldwide will double between 2000 and 2030, almost reaching a pandemic level of 366 million people. The fastest growing segment is Alzheimer’s disease in the global medical foods market for the forecast period 2017-2025, due rising incidence of Alzheimer’s disease.

In the base year 2016, North America dominated the global medical foods market which was followed by Europe. The key market drivers assisting in the growth of North America medical food industry comprises rise in aging population, shifting trend towards enteral nutrition, and increasing demand for personalized medicine. Thus, North America medical food market is expected to maintain its growth throughout the forecast period due to increasing support from nutritionist and physicians as a supplement to drug treatment. Asia Pacific is expected to be the fastest growing region due to growing acceptance towards supplements and enteral nutrition. Moreover, large population of diseases such as diabetes, age related disorders in the region is further fueling the market growth in Asia Pacific.

Market Competition Assessment

The prenatal vitamin supplements market currently have numerous companies having their products marketed. However, most of the companies are located in the North America and others developed regions. The companies have untapped opportunities in the developing regions of Asia Pacific and Latin America. Companies are coming up with various products in the developed nations due to high acceptance and accessibilities of these products. Packaged foods giant Nestlé S.A. is expanding its footprint in the global nutrition sector by tapping into market for medical foods with prescription-based powders and drinks intended to meet specific nutritional requirements to treat diseases. The major companies in the medical food market include Abbott Laboratories, Nestle S.A., Danone S.A., Fresenius Kabi, Valeant Pharmaceuticals, Entera Health, Metagenics, Inc., Mead Johnson & Company and Others.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Danone S.A
  • Entera Health,
  • Fresenius Kabi AG
  • Metagenics, Inc.
  • Nestle S.A.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Medical Foods Market Portraiture
2.2 Medical Foods Market, by Therapeutic Type, 2016 (US$ Mn)
2.3 Medical Foods Market, by Application Type, 2016 (US$ Mn)
2.4 Medical Foods Market, by Geography, 2016 (Value %)

Chapter 3 Global Medical Foods Market Analysis
3.1 Global Medical Foods Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Growing Demand for Personalized Medicine
3.2.1.2 Significant Growth in Geriatric Population
3.2.1.3 Growing Preference to Enteral Nutrition
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Medical Foods Market, 2016 (Value %)

Chapter 4 Global Medical Foods Market Analysis, By Therapeutic Type
4.1 Overview
4.1.1 Market Attractive Proposition of Medical Foods Market, by Therapeutic Type, 2016
4.2 Pain Management
4.3 Sleep Management
4.4 Obesity and Hypertension
4.5 Cognitive Disorders
4.6 Viral Infections
4.7 Neuro-Degenerative Disorders
4.8 Inborn Errors of Metabolism

Chapter 5 Global Medical Foods Market Analysis, By Application Type
5.1 Overview
5.1.1 Market Attractive Proposition of Medical Foods Market, by Application Type, 2016
5.2 Diabetic Neuropathy
5.3 ADHD
5.4 Depression
5.5 Alzheimer’s Disease
5.6 Nutritional Deficiency
5.7 Others

Chapter 6 Global Medical Foods Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.2.1 North America Medical Foods Market, by Therapeutic Type, 2015-2025 (US$ Mn)
6.2.2 North America Medical Foods Market, by Application Type, 2015-2025 (US$ Mn)
6.2.3 North America Medical Foods Market, by Country, 2015 - 2025 (US$ Mn)
6.3 Europe (U.K., Germany & Rest of Europe)
6.3.1 Europe Medical Foods Market, by Therapeutic Type, 2015-2025 (US$ Mn)
6.3.2 Europe Medical Foods Market, by Application Type, 2015-2025 (US$ Mn)
6.3.3 Europe Medical Foods Market, by Country, 2015 - 2025 (US$ Mn)
6.4 Asia-Pacific (China, Japan & Rest of Asia-Pacific)
6.4.1 Asia Pacific Medical Foods Market, by Therapeutic Type, 2015-2025 (US$ Mn)
6.4.2 Asia Pacific Medical Foods Market, by Application Type, 2015-2025 (US$ Mn)
6.4.3 Asia - Pacific Medical Foods Market, by Country, 2015 - 2025 (US$ Mn)
6.5 Latin America (Brazil, Mexico and Rest of LATAM)
6.5.1 Latin America Medical Foods Market, by Therapeutic Type, 2015-2025 (US$ Mn)
6.5.2 Latin America Medical Foods Market, by Application Type, 2015-2025 (US$ Mn)
6.5.3 Latin America Medical Foods Market, by Country, 2015 - 2025 (US$ Mn)
6.6 Middle East and Africa
6.6.1 Middle East and Africa Medical Foods Market, by Therapeutic Type, 20152025 (US$ Mn)
6.6.2 Middle East and Africa Medical Foods Market, by Application Type, 2015- 2025 (US$ Mn)
6.6.3 Middle East and Africa Applications Market, by Country, 2015 - 2025 (US$ Mn)

Chapter 7 Company Profiles 7.1 Abbott Laboratories
7.2 Nestle S.A.
7.3 Danone S.A
7.4 Primus Pharmaceuticals, Inc.
7.5 Fresenius Kabi AG
7.6 Metagenics, Inc.
7.7 Mead Johnson & Company, LLC
7.8 MicroBiome Therapeutics LLC
7.9 Proliant Health and Biologicals (a division of Proliant, Inc.)
7.10 Entera Health, Inc.
7.11 Valeant Pharmaceuticals
7.12 Vaya Pharma, Inc. USA
7.13 Upsher-Smith Laboratories, LLC
7.14 Physician Therapeutics, LLC

List of Figures
Fig. 1 Medical Foods Market: Research Methodology
Fig. 2 Medical Foods Market, by Therapeutic Type, 2016 (US$ Mn)
Fig. 3 Medical Foods Market, by Application Type, 2016 (US$ Mn)
Fig. 4 Medical Foods Market, by Geography, 2016 (Value %)
Fig. 5 Attractive Investment Proposition
Fig. 6 Competitive Analysis: Global Medical Foods Market, 2016 (Value %)
Fig. 7 Global Pain Management Market(US$ Mn), 2015-2025
Fig. 8 Global Sleep Management Market(US$ Mn), 2015-2025
Fig. 9 Global Obesity and Hypertension Market (US$ Mn), 2015-2025
Fig. 10 Global Cognitive Disorders Market (US$ Mn), 2015-2025
Fig. 11 Global Viral Infections Market (US$ Mn), 2015-2025
Fig. 12 Global Neuro-Degenerative Disorders Market(US$ Mn), 2015-2025
Fig. 13 Global Inborn Errors of Metabolism Market (US$ Mn), 2015-2025
Fig. 14 Global Diabetic Neuropathy Market(US$ Mn), 2015-2025
Fig. 15 Global ADHD Market(US$ Mn), 2015-2025
Fig. 16 Global Depression Market (US$ Mn), 2015-2025
Fig. 17 Global Alzheimer’s Disease Market (US$ Mn), 2015-2025
Fig. 18 Global Nutritional Deficiency Market (US$ Mn), 2015-2025
Fig. 19 Global Others Applications Market(US$ Mn), 2015-2025

List of Tables
Table 1 Global Medical Foods Market, By Therapeutic Type (US$ Mn), 2015- 2025 (Value)
Table 2 Global Medical Foods Market, By Application Type (US$ Mn), 2015- 2025 (Value)
Table 3 Global Medical Foods Market, by Geography, 2015 - 2025 (US$ Mn)
Table 4 North America Medical Foods Market, by Therapeutic Type, 2015 - 2025 (US$ Mn)
Table 5 North America Medical Foods Market, by Application Type, 2015 - 2025 (US$ Mn)
Table 6 North America Medical Foods Market, by Country, 2015 - 2025 (US$ Mn)
Table 7 Europe Medical Foods Market, by Therapeutic Type, 2015 - 2025 (US$ Mn)
Table 8 Europe Medical Foods Market, by Application Type, 2015 - 2025 (US$ Mn)
Table 9 Europe Medical Foods Market, by Country, 2015 - 2025 (US$ Mn)
Table 10 Asia Pacific Medical Foods Market, by Therapeutic Type, 2015 - 2025 (US$ Mn)
Table 11 Asia Pacific Medical Foods Market, by Application Type, 2015 - 2025 (US$ Mn)
Table 12 Asia - Pacific Medical Foods Market, by Country, 2015 - 2025 (US$ Mn)
Table 13 Latin America Medical Foods Market, by Therapeutic Type, 2015 - 2025 (US$ Mn)
Table 14 Latin America Medical Foods Market, by Application Type, 2015 - 2025 (US$ Mn)
Table 15 Latin America Medical Foods Market, by Country, 2015 - 2025 (US$ Mn)
Table 16 Middle East and Africa Medical Foods Market, by Therapeutic Type, 2015 - 2025 (US$
Mn)
Table 17 Middle East and Africa Medical Foods Market, by Applications Type, 2015 - 2025 (US$
Mn)
Table 18 Middle East and Africa Applications Market, by Country, 2015 - 2025 (US$ Mn)
Table 19 Abbott Laboratories: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
Table 20 Nestle S.A.: Company Snapshot (Business Description; Financial Performance; Product
Position/Portfolio; News Coverage)
Table 21 Danone S.A: Company Snapshot (Business Description; Financial Performance; Product
Position/Portfolio; News Coverage)
Table 22 Primus Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
Table 23 Fresenius Kabi AG: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
Table 24 Metagenics, Inc.: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
Table 25 Mead Johnson & Company, LLC: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
Table 26 MicroBiome Therapeutics LLC: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
Table 27 Proliant Health and Biologicals (a division of Proliant, Inc.): Company Snapshot (Business
Description; Financial Performance; Product Position/Portfolio; News Coverage)
Table 28 Entera Health, Inc.: Company Snapshot (Business Description; Financial Performance;
Product Position/Portfolio; News Coverage)
Table 29 Valeant Pharmaceuticals: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
Table 30 Vaya Pharma, Inc. USA: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
Table 31 Upsher-Smith Laboratories, LLC: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
Table 32 Physician Therapeutics, LLC: Company Snapshot (Business Description; Financial
Performance; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Nestle S.A.
  • Danone S.A
  • Primus Pharmaceuticals, Inc.
  • Fresenius Kabi AG
  • Metagenics, Inc.
  • Mead Johnson & Company, LLC
  • MicroBiome Therapeutics LLC
  • Proliant Health and Biologicals (a division of Proliant, Inc.)
  • Entera Health,
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll